LLY

927.24

-5.67%↓

JNJ

239.19

-1.28%↓

ABBV

221.99

+0.16%↑

NVS

155.04

+0.27%↑

AZN

190.98

-0.45%↓

LLY

927.24

-5.67%↓

JNJ

239.19

-1.28%↓

ABBV

221.99

+0.16%↑

NVS

155.04

+0.27%↑

AZN

190.98

-0.45%↓

LLY

927.24

-5.67%↓

JNJ

239.19

-1.28%↓

ABBV

221.99

+0.16%↑

NVS

155.04

+0.27%↑

AZN

190.98

-0.45%↓

LLY

927.24

-5.67%↓

JNJ

239.19

-1.28%↓

ABBV

221.99

+0.16%↑

NVS

155.04

+0.27%↑

AZN

190.98

-0.45%↓

LLY

927.24

-5.67%↓

JNJ

239.19

-1.28%↓

ABBV

221.99

+0.16%↑

NVS

155.04

+0.27%↑

AZN

190.98

-0.45%↓

Search

Guardant Health Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

88.15 1.09

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

86.37

Max

88.88

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

2,490

EBITDA

-37M

-119M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+52.24% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-04-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.7B

12B

Ankstesnė atidarymo kaina

87.06

Ankstesnė uždarymo kaina

88.15

Naujienos nuotaikos

By Acuity

50%

50%

150 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-16 21:37; UTC

Įsigijimai, susijungimai, perėmimai

Lensar and Alcon Agree to Terminate Merger

2026-03-16 19:06; UTC

Svarbiausios naujienos

Mideast Loses 12 Million Boe/d Following Hormuz Closure: Rystad -- OPIS

2026-03-16 17:44; UTC

Įsigijimai, susijungimai, perėmimai

Novartis Issues Debt Offering to Help Fund $12 Billion Acquisition of Avidity Biosciences

2026-03-16 23:46; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-16 23:46; UTC

Rinkos pokalbiai

Nikkei May Rise After Oil Prices Decline -- Market Talk

2026-03-16 23:37; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Technical Recovery -- Market Talk

2026-03-16 23:05; UTC

Rinkos pokalbiai

Slumping Consumer Confidence Highlights Risk Around RBA Hike -- Market Talk

2026-03-16 21:56; UTC

Rinkos pokalbiai

DUG Technology's Stock Fall Creates Opportunity -- Market Talk

2026-03-16 21:41; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-16 21:41; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Clouds Gather Over Auckland Intl Airport as Airlines Up Fares -- Market Talk

2026-03-16 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

2026-03-16 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

2026-03-16 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

2026-03-16 20:57; UTC

Įsigijimai, susijungimai, perėmimai

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

2026-03-16 20:51; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia-Backed Nscale Plans Huge Data Center Cluster in West Virginia -- WSJ

2026-03-16 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-16 20:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Energy & Utilities Roundup: Market Talk

2026-03-16 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-03-16 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-16 19:53; UTC

Svarbiausios naujienos

U.S. Allies Rebuff Trump's Demand for Help Opening Strait of Hormuz -- WSJ

2026-03-16 19:43; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-16 19:43; UTC

Rinkos pokalbiai

Nvidia Sees $1 Trillion in Blackwell, Rubin Orders Through 2027 -- Market Talk

2026-03-16 19:37; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Natural Gas Follows Oil Prices Lower -- Market Talk

2026-03-16 19:20; UTC

Svarbiausios naujienos

Stock Market Today: Dow Jumps, Brent Crude Pulls Back From $105 -- WSJ

2026-03-16 19:17; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Crude Oil Sinks on Signals from Strait of Hormuz -- Market Talk

2026-03-16 19:00; UTC

Rinkos pokalbiai

Bank of Canada Needs Dovish Approach Based on Weak Data -- Market Talk

2026-03-16 18:23; UTC

Rinkos pokalbiai

LME Restarts Trading After Outage -- Market Talk

2026-03-16 17:36; UTC

Svarbiausios naujienos

Oil Prices Fall as Trump Says Hormuz Help Is Coming. Tankers Getting Through, Bessent Adds. -- Barrons.com

2026-03-16 17:19; UTC

Rinkos pokalbiai

Grains Sink as Investors Steer Toward Equities -- Market Talk

2026-03-16 17:14; UTC

Svarbiausios naujienos

Trump Ends News Conference

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

52.24% į viršų

12 mėnesių prognozė

Vidutinis 132.72 USD  52.24%

Aukščiausias 175 USD

Žemiausias 110 USD

Remiantis 20 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

20 ratings

19

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

150 / 351 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat